Current Cancer Drug Targets
Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Cancer Drug Targets, Volume 12 - Number 7
Editorial
Targeted Therapy of Multiple Myeloma: The Changing Paradigm at the Beginning of the New Millennium
, 12(7): 743 - 756Fortunato Morabito, Anna Grazia Recchia, Carla Mazzone and Massimo Gentile
DOI: 10.2174/156800912802429373
Molecular Targets for the Treatment of Multiple Myeloma
, 12(7): 757 - 767Marco Rossi, Maria Teresa Di Martino, Eugenio Morelli, Marzia Leotta, Antonietta Rizzo, Anna Grimaldi, Gabriella Misso, Pierfrancesco Tassone and Michele Caraglia
DOI: 10.2174/156800912802429300
Antiangiogenic Therapeutic Approaches in Multiple Myeloma
, 12(7): 768 - 775Domenico Ribatti, Giuseppe Mangialardi and Angelo Vacca
DOI: 10.2174/156800912802429346
Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma
, 12(7): 776 - 796Paola Neri and Nizar J. Bahlis
DOI: 10.2174/156800912802429337
Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma
, 12(7): 814 - 822P. Tassone, P. Neri, R. Burger, M. T. Di Martino, E. Leone, N. Amodio, M. Caraglia and P. Tagliaferri
DOI: 10.2174/156800912802429292
MicroRNAs in the Pathobiology of Multiple Myeloma
, 12(7): 823 - 837Marta Lionetti, Luca Agnelli, Luigia Lombardi, Pierfrancesco Tassone and Antonino Neri
DOI: 10.2174/156800912802429274
Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
, 12(7): 838 - 846P. Tagliaferri, M. Rossi, M. T. Di Martino, N. Amodio, E. Leone, A. Gulla, A. Neri and P. Tassone
DOI: 10.2174/156800912802429355
Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells
, 12(7): 847 - 856K. Koike, Y. Ueda, H. Hase, K. Kitae, Y. Fusamae, S. Masai, T. Inagaki, Y. Saigo, S. Hirasawa, K. Nakajima, I. Ohshio, Y. Makino, N. Konishi, H. Yamamoto and K. Tsujikawa
DOI: 10.2174/156800912802429283
A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma
, 12(7): 857 - 872Z. Mihaly, Z. Sztupinszki, P. Surowiak and B. Gyorffy
DOI: 10.2174/156800912802429265
A Molecular Signature for Oncogenic BRAF in Human Colon Cancer Cells is Revealed by Microarray Analysis
, 12(7): 873 - 898T. Joyce, E. Oikonomou, V. Kosmidou, E. Makrodouli, I. Bantounas, S. Avlonitis, G. Zografos and A. Pintzas
DOI: 10.2174/156800912802429364
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Advertisement
Webmaster Contact: info@benthamscience.net